Related by context. Frequent words. (Click for all words.) 77 FDA Clears 76 Completes Enrollment 75 Receives FDA Clearance 73 Receives Patent 73 Significantly Reduces 72 Awarded Patent 72 Clinical Trial Results 72 Presents Positive 71 Drug Candidate 71 Signs Licensing Agreement 71 Files Patent 71 Achieves Milestone 71 Announces Initiation 70 Reduces Risk 70 Patient Enrollment 70 Phase III Clinical Trial 70 Announces Publication 69 FDA Approves 69 Technol 69 Q2 Loss Narrows 69 Generic Version 69 Phase III Trial 69 Low Dose 69 Signs Agreements 68 Shows Promise 68 Q3 Loss Narrows 68 Q1 Loss Narrows 68 Reports Positive 68 Q2 Loss Widens 68 FDA Accepts 68 Secures Additional 67 Introduces Next Generation 67 Announces Issuance 67 FDA Clearance 67 FDA Warns 67 Tianyin Pharmaceutical Co. 67 Initiates Phase 67 Non Invasive 67 Provides Guidance 67 Report companiesandmarkets.com adds 66 Q3 Loss Widens 66 Cholesterol Drug 66 Subsidiary Signs 66 Pivotal Phase III 66 Regains Compliance 66 Preclinical Data 66 Begins Shipping 66 Pivotal Trial 66 Announce Collaboration 66 Develop Next Generation 66 Unveils Latest 66 Equipment Deals 66 Complete Merger 66 Finalizes Acquisition 66 Subsidiary Receives 66 Reports Profitable 66 Introduces Innovative 66 Inc Therapeutic Competitors 65 Announces Positive 65 Completes Merger 65 Small Molecule 65 Enters Agreement 65 Announces Definitive Agreement 65 Strengthens Its 65 Enters Into Letter 65 Pulmonary Arterial Hypertension 65 Updates Shareholders 65 Combination Therapy 65 Updates Guidance 65 Inhibits 65 Further Strengthens 65 Q4 Loss Widens 65 Receives Positive 65 Announces Termination 65 China Aoxing Pharmaceutical 65 Acquire Assets 65 Unveils Innovative 65 Announces Signing 65 Secures Funding 65 Announces Enhancements 65 Announces Presentation 65 Pivotal Phase 65 Q1 Loss Widens 64 Announces Successful Completion 64 Atopic Dermatitis 64 Elderly Patients 64 AP PhotoExpress Network 64 Cancer Treatments 64 Study Demonstrates 64 Patients Treated 64 Prostate Cancer Patients 64 Report Analyzes 64 Receives CE 64 Signs LOI 64 Fully Automated 64 Extends Tender Offer 64 Announces Additions 64 Provides Preliminary 64 Commences Trading 63 Launches Next Generation 63 Drug Resistant